All articles by Daniel Garrun

Daniel Garrun

Cyatt and CardioComm sign JV agreement for patient monitoring technology

US-based health technology solutions provider Cytta has signed a joint venture (JV) agreement with Canadian cardiovascular devices firm CardioComm Solutions for a remote patient monitoring platform, VeriSmartPhone.

GenePOC releases new test for Group B Streptococcus in Europe

Canada-based diagnostic devices maker GenePOC has introduced its GenePOC Group B Streptococcus (GBS) Direct Swab (DS) molecular test in Europe to reduce the risk of transmission from mother to newborn.

University of Texas to develop cheap at-home test for heart failure

A research team at the University of Texas, US, is set to develop an affordable at-home diagnostic test for patients with heart failure.

DePuy Synthes unveils new screw system for spinal fusion surgery

Johnson and Johnson’s DePuy Synthes has unveiled its new minimally invasive surgery (MIS) pedicle screw system, Viper Prime, to improve MIS spinal fusion surgery.

Flirtey and REMSA to launch AED drones for cardiac arrest victims in US

Regional Emergency Medical Services Authority (REMSA) has collaborated with drone delivery service provider Flirtey to launch an automated external defibrillator (AED) drone delivery programme in the US.

Respicardia gets FDA approval for remede system to treat sleep apnea

The US Food and Drug Administration (FDA) has approved Respicardia’s transvenous implantable neurostimulation system, remedē, for moderate to severe central sleep apnea (CSA) in adults.

CryoLife to buy Germany’s Jotec for $225m

US-based firm CryoLife has signed a definitive agreement to purchase German vascular grafts maker Jotec for an upfront payment of $225m, subject to adjustments.

ICR researchers demonstrate use of genetic test for prostate cancer therapy

Scientists from the Cancer Biomarkers laboratory team of the Institute of Cancer Research in the UK have carried out research to demonstrate the use of a quick genetic test for the targeted treatment of prostate cancer.

FDA approves LivaNova’s VNS therapy system for epilepsy

UK-based firm LivaNova has obtained approval from the US Food and Drug Administration (FDA) for its new Vagus Nerve Stimulation (VNS) Therapy System designed to treat drug-resistant epilepsy.

Synaptive Medical introduces new surgical robotic device

Canadian firm Synaptive Medical has introduced its second-generation, high-powered Modus V digital microscope that has a robotic arm to aid neurosurgery.